key: cord-0910734-u531mnwc authors: Hakmi, Hazim; Sohail, Amir; Brathwaite, Collin; Ray, Beevash; Abrol, Sunil title: Cardiac tamponade in COVID‐19 patients: Management and outcomes date: 2020-08-13 journal: J Card Surg DOI: 10.1111/jocs.14925 sha: 7e61adbb0f0f8bd4fc44236d004772f7a398d683 doc_id: 910734 cord_uid: u531mnwc IMPORTANCE: Cardiac tamponade requiring emergent intervention is a possible complication of coronavirus disease 2019 (COVID‐19) infection. Favorable clinical outcomes are possible if timely management and drainage are performed unless ventricular failure develops. OBSERVATION: Cardiac tamponade in COVID‐19, based on the limited reported cases, seems to be more common among middle‐aged men with observed complications in black and ethnic minorities. Prognosis is worse amongst patients with concomitant ventricular failure. DESIGN AND METHODS: This is a case series of three COVID‐19 patients complicated by cardiac tamponade, requiring surgical intervention at a single institution in New York. INTERVENTION: Pericardial window, Pericardiocentesis. OUTCOME: One patient had recurrence of cardiac tamponade with hemorrhagic component but fully recovered and was discharged home. Two patients developed cardiac tamponade with concomitant biventricular failure, resulting in death. CONCLUSION AND RELEVANCE: Cardiac tamponade with possible concomitant biventricular failure can develop in COVID‐19 patients; incidence seems to be highest at the point of marked inflammatory response. Concomitant ventricular failure seems to be a predictor of poor prognosis. disease in COVID-19 infection. Thus, therapeutic dose anticoagulation and anti-inflammatory medications could possibly play a role in treatment of patients with COVID-19. However, it is important to be cognizant of hemorrhagic sequalae and immunosuppressive side effects of these medications. The World Health Organization declared the coronavirus disease 2019 (COVID-19) outbreak as a pandemic on 11 March 2020. 1 With its rapid spread across the globe, physicians have encountered a broad spectrum of early and late complications-mostly resulting from the underlying inflammatory process-including acute respiratory distress syndrome, acute kidney injury, and secondary infection. 2 Mortality among hospitalized patients with COVID-19 has been reported to be as high as 17%, with the figure being 20.5% in patients undergoing elective surgeries. 3, 4 There is paucity of data regarding the cardiovascular effects of COVID-19. Arrhythmias, myocarditis, hypercoagulability, congestive heart failure, and, surprisingly, two cases of cardiac tamponade physiology, both resulting from hemorrhagic pericardial effusion, have been reported. [5] [6] [7] [8] We further report three cases of COVID-19 complicated by cardiac tamponade requiring emergent surgical intervention. showed a moderate-to-large pericardial effusion with tamponade physiology (Figure 1 ). He underwent emergent percutaneous drainage of 1500 mL of clear pericardial fluid which was sent for cytology (Table 1) and was started on therapeutic anticoagulation. On postoperative day (POD) 8, the patient developed acute cardiovascular decompensation. An ECHO showed a large pericardial fluid collection with signs of obstructive shock ( Figure 2 ). He underwent another pericardial drainage with 900 mL of sanguineous fluid drained (no associated bacterial organisms on fluid culture), and was switched to prophylactic dose anticoagulation. Postoperative course was unremarkable, and patient was discharged 10 days after the second procedure in stable condition with drop in his inflammatory markers after Pericardiocentesis (Table 2) . population is yet to be determined. 16, 17 High suspicion for recurrence of cardiac tamponade is warranted as risk of recurrence is as high as 20%. 18 While current data on cardiac tamponade, with possible First case of novel coronavirus in the United States Clinical features of patients infected with 2019 novel coronavirus in Wuhan Characteristics and clinical outcomes of adult patients hospitalized with COVID-19-Georgia Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection Cardiovascular complications of severe acute respiratory syndrome Cardiac tamponade secondary to COVID-19 Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19 Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) Acute cardiac tamponade Pericardial disease: diagnosis and management Pericardial decompression syndrome: a comprehensive review COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure COVID-19 pathophysiology: a review Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Periprocedural anticoagulation of patients undergoing pericardiocentesis for cardiac tamponade complicating catheter ablation of atrial fibrillation Misguided drug advice for COVID-19 Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) Frequency of recurrence of pericardial tamponade in patients with extended versus nonextended pericardial catheter drainage COVID-19 illness and heart failure Cardiovascular complications in COVID-19 COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options Sharpening the global focus on ethnicity and race in the time of COVID-19 Cardiac tamponade in COVID-19 patients: Management and outcomes The authors declare that there are no conflict of interests. http://orcid.org/0000-0003-4632-2913